Export Market Plan

Feedback from Discussion on Placement (Channels, Distribution & Supply Chain)

It seems like you are somewhat mixing market entry methods. 

Licensing is a transfer-related market entry strategy. It involves a company (known as the licensor) granting permission to a company in another country to use its intellectual property for a defined time period.  Is there IP for making insulin which can be transferred?

What type of company would be a licensee? what is the criteria to select a German licensee to make your insulin? (The two tiers of promotion are from the US company to the German licensee and then from the German licensee to German diabetes patients)

In your report you will want to include a diagram of how the German sales channels for insulin works.

You will need to briefly explain what should be in your International Manufacturing License Agreement and the International Trademark License Agreement since you are proposing licenses as a market entry method rather than distributor, agent, etc.

Sounds like you are not proposing to physically ship insulin from the US to Germany, but instead just a "formula" for insulin?

Here's how the supply chain flows for insulin.  You're correct about all ages being candidates for insulin therapy.  Type 1 Diabetics spend their entire lifetime on the manufactured hormone.  Type 2 Diabetics usually develop diabetes later on in life and it is brought on by lifestyle, ie lack of exercise, obesity, genetics, and poor eating habits.  For T1D, insulin is the only option.  For T2D, their therapy depends on how high their A1C is.  The provider will tell them to try diet and exercise as prediabetics, and once they are diagnosed with diabetes, metformin is prescribed.  As the A1C rises, other meds are added on to therapy (SGLT2 inhibitors, DPP4 inhibitors, GLP1 receptor agonists, Sulfonylureas, and then Insulin if the A1C is too high).  

Good Job!